We are looking for young people 2 to 17 years of age to join a clinical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or moderate to severe IBD (including associated symptoms such as diarrhea with blood, kidney stones, abdominal pain, frequent fevers and/or canker sores), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
